Explore the categories so you can find more about your search.

Categorie > Irritable-Bowel Syndrome

CeRPTA Develops New Gluten-free Bread Of A Much Higher Quality Than Products Currently Available For Coeliacs

Categorie : Irritable-Bowel Syndrome
Researchers at the Food Technology Plant Special Research Centre (CeRPTA) have for the first time developed a completely gluten-free bread that is of a much higher quality than products currently available for coeliacs. The product was 100% successful in the tests carried out. The resulting prod ...

read more Researchers at the Food Technology Plant Special Research Centre (CeRPTA) have for the first time developed a completely gluten-free bread that is of a much higher quality than products currently available for coeliacs. The product was 100% successful in the tests carried out. The resulting prod read more Sun Oct 2007 Sun Oct 2007

Lubiprostone May Improve Symptom Relief Rates In Adults With IBS-C

Categorie : Irritable-Bowel Syndrome
A new study demonstrated that the active ingredient in AMITIZA® (lubiprostone), given 8 mcg twice a day, may improve symptom relief rates in adults with irritable bowel syndrome with constipation (IBS-C). These results were presented as a late-breaker at Digestive Disease Week 2007, the ...

read more A new study demonstrated that the active ingredient in AMITIZA® (lubiprostone), given 8 mcg twice a day, may improve symptom relief rates in adults with irritable bowel syndrome with constipation (IBS-C). These results were presented as a late-breaker at Digestive Disease Week 2007, the read more Sun Oct 2007 Sun Oct 2007

PDL BioPharma Announces Long-Term Nuvion(R) Data Presented At 2007 Digestive Disease Week

Categorie : Irritable-Bowel Syndrome
Data presented at the Digestive Disease Week (DDW) meeting this week in Washington D.C. by Dr. William Sandborn from the Mayo Clinic suggest that Nuvion (visilizumab), an antibody in development as a treatment for intravenous steroid-refractory ulcerative colitis (IVSR-UC), administered on d ...

read more Data presented at the Digestive Disease Week (DDW) meeting this week in Washington D.C. by Dr. William Sandborn from the Mayo Clinic suggest that Nuvion (visilizumab), an antibody in development as a treatment for intravenous steroid-refractory ulcerative colitis (IVSR-UC), administered on d read more Sun Oct 2007 Sun Oct 2007

Zelnorm(R) To Be Made Available To US Patients Under Restricted Access Program

Categorie : Irritable-Bowel Syndrome
In cooperation with the US Food and Drug Administration (FDA), Novartis has established a restricted access program for Zelnorm(R) (tegaserod maleate) so that patients in need of this medicine can be considered for treatment. [click link for full article] ...

read more In cooperation with the US Food and Drug Administration (FDA), Novartis has established a restricted access program for Zelnorm(R) (tegaserod maleate) so that patients in need of this medicine can be considered for treatment. [click link for full article] read more Sun Oct 2007 Sun Oct 2007

Supplemental New Drug Application For Lubiprostone To Treat IBS With Constipation Submitted By Sucampo Pharmaceuticals

Categorie : Irritable-Bowel Syndrome
Sucampo Pharmaceuticals, Inc., (Sucampo Pharmaceuticals) has announced that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration to seek market approval of a lower strength of lubiprostone (8 mcg) to treat irritable bowel syndrome with constipation (IBS-C ...

read more Sucampo Pharmaceuticals, Inc., (Sucampo Pharmaceuticals) has announced that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration to seek market approval of a lower strength of lubiprostone (8 mcg) to treat irritable bowel syndrome with constipation (IBS-C read more Sun Oct 2007 Sun Oct 2007

Sucampo Pharmaceuticals Submits Supplemental New Drug Application For Lubiprostone To Treat Irritable Bowel Syndrome With Constipation

Categorie : Irritable-Bowel Syndrome
Sucampo Pharmaceuticals, Inc., (Sucampo Pharmaceuticals) today announced that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration to seek market approval of a lower strength of lubiprostone (8 mcg) to treat irritable bowel syndrome with constipation (IBS ...

read more Sucampo Pharmaceuticals, Inc., (Sucampo Pharmaceuticals) today announced that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration to seek market approval of a lower strength of lubiprostone (8 mcg) to treat irritable bowel syndrome with constipation (IBS read more Sun Oct 2007 Sun Oct 2007

Heart Drugs May Help People With Bowel Disorders

Categorie : Irritable-Bowel Syndrome
Statin drugs which are widely prescribed to prevent heart disease may emerge as a future treatment for Crohn's disease, an inflammatory bowel condition, a scientist said last Tuesday. Surgical research fellow Dr. John Burke was addressing the Association of Coloproctology meeting in Glagow about ...

read more Statin drugs which are widely prescribed to prevent heart disease may emerge as a future treatment for Crohn's disease, an inflammatory bowel condition, a scientist said last Tuesday. Surgical research fellow Dr. John Burke was addressing the Association of Coloproctology meeting in Glagow about read more Sun Oct 2007 Sun Oct 2007

FDA Accepts Sucampo's SNDA For Lubiprostone (8 Mcg) For The Treatment Of Irritable Bowel Syndrome With Constipation (IBS-C)

Categorie : Irritable-Bowel Syndrome
Sucampo Pharmaceuticals, Inc., (Nasdaq: SCMP) announced that the supplemental New Drug Application (sNDA) for lubiprostone (8 mcg, oral gel capsules, twice daily) for the treatment of irritable bowel syndrome with constipation (IBS-C) has been accepted for review by the U.S. Food and Drug Admini ...

read more Sucampo Pharmaceuticals, Inc., (Nasdaq: SCMP) announced that the supplemental New Drug Application (sNDA) for lubiprostone (8 mcg, oral gel capsules, twice daily) for the treatment of irritable bowel syndrome with constipation (IBS-C) has been accepted for review by the U.S. Food and Drug Admini read more Sun Oct 2007 Sun Oct 2007

Lexicon Presents Class Of Compounds Modulating TPH1, The Target For Its LX1031 Investigational Drug For Irritable Bowel Syndrome

Categorie : Irritable-Bowel Syndrome
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) presented data today describing the structure-activity relationship (SAR) of a class of internally-developed compounds that includes LX1031 and other compounds under evaluation by the company as potential treatments for irritable bowel syndrome ( ...

read more Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) presented data today describing the structure-activity relationship (SAR) of a class of internally-developed compounds that includes LX1031 and other compounds under evaluation by the company as potential treatments for irritable bowel syndrome ( read more Sun Oct 2007 Sun Oct 2007

Important Facts About Irritable Bowel Syndrome

Categorie : Irritable-Bowel Syndrome
Irritable Bowel Syndrome (IBS) is a disorder of bowel function. Patients who suffer from irritable bowel syndrome have abdominal pain or discomfort accompanied by changes in bowel habits such as constipation or diarrhea (or both). Additional symptoms of IBS include abdominal bloating, loss of appeti ...

read more Irritable Bowel Syndrome (IBS) is a disorder of bowel function. Patients who suffer from irritable bowel syndrome have abdominal pain or discomfort accompanied by changes in bowel habits such as constipation or diarrhea (or both). Additional symptoms of IBS include abdominal bloating, loss of appeti read more Sun Oct 2007 Sun Oct 2007

Management Of Inflammatory Bowel Disease Improved By Biologics

Categorie : Irritable-Bowel Syndrome
The use of biologic agents for the treatment of inflammatory bowel disease (IBD) may benefit patients, but doctors need to consider the potential associated side effects in determining treatment course, according to a consensus paper published in this month's issue of Gastroenterology, the official ...

read more The use of biologic agents for the treatment of inflammatory bowel disease (IBD) may benefit patients, but doctors need to consider the potential associated side effects in determining treatment course, according to a consensus paper published in this month's issue of Gastroenterology, the official read more Sun Oct 2007 Sun Oct 2007

Cancer Protection and Mesalamine Linked For High Risk Inflammatory Bowel Disease Patients

Categorie : Irritable-Bowel Syndrome
Colorectal screening remains essential for those with IBDResearchers found that mesalamine use among patients with inflammatory bowel disease was associated with a decrease in incidence of colorectal cancer when comparing cases and controls. [click link for full article] ...

read more Colorectal screening remains essential for those with IBDResearchers found that mesalamine use among patients with inflammatory bowel disease was associated with a decrease in incidence of colorectal cancer when comparing cases and controls. [click link for full article] read more Sun Oct 2007 Sun Oct 2007

Results Of Review Of Probiotic Research

Categorie : Irritable-Bowel Syndrome
A new analysis of randomized controlled trials evaluating probiotics in the treatment of irritable bowel syndrome (IBS) has found that Bifantis®, Bifidobacterium infantis 35624, the sole ingredient in Align® (manufactured by Procter & Gamble), is the only probiotic currently able to de ...

read more A new analysis of randomized controlled trials evaluating probiotics in the treatment of irritable bowel syndrome (IBS) has found that Bifantis®, Bifidobacterium infantis 35624, the sole ingredient in Align® (manufactured by Procter & Gamble), is the only probiotic currently able to de read more Sun Oct 2007 Sun Oct 2007

A Psychological Approach To The Management Of Irritable Bowel Syndrome

Categorie : Irritable-Bowel Syndrome
Antidepressants and psychological treatments such as hypnotherapy have the potential to help patients with severe irritable bowel syndrome (IBS), say researchers in this week's BMJ.IBS is a very common disorder, but conventional 'physical' treatments often do not work very well and patients can feel ...

read more Antidepressants and psychological treatments such as hypnotherapy have the potential to help patients with severe irritable bowel syndrome (IBS), say researchers in this week's BMJ.IBS is a very common disorder, but conventional 'physical' treatments often do not work very well and patients can feel read more Wed May 2007 Wed May 2007

Proteases Cause Pain In Irritable Bowel Syndrome

Categorie : Irritable-Bowel Syndrome
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder in the developed world. It is characterized by altered bowel function, abdominal discomfort, and pain. However, there are few effective treatments for IBS, in part because the molecular mechanisms underlying the disease symptoms ha ...

read more Irritable bowel syndrome (IBS) is a common gastrointestinal disorder in the developed world. It is characterized by altered bowel function, abdominal discomfort, and pain. However, there are few effective treatments for IBS, in part because the molecular mechanisms underlying the disease symptoms ha read more Mon Feb 2007 Mon Feb 2007

Novartis Committed To Making Zelnorm(R) Available For Women With Irritable Bowel Syndrome With Constipation In Europe

Categorie : Irritable-Bowel Syndrome
Novartis will appeal an opinion from a European Medicines Agency (EMEA) committee recommending against European approval of Zelnorm(R) (tegaserod) for the treatment of women with irritable bowel syndrome with constipation (IBS-C). Novartis decided to take this action after the European Committee for ...

read more Novartis will appeal an opinion from a European Medicines Agency (EMEA) committee recommending against European approval of Zelnorm(R) (tegaserod) for the treatment of women with irritable bowel syndrome with constipation (IBS-C). Novartis decided to take this action after the European Committee for read more Tue Dec 2006 Tue Dec 2006

Konsyl (REG) Original Provides More Fiber Per Dose Than Traditional Bulk Forming Laxatives

Categorie : Irritable-Bowel Syndrome
Konsyl Pharmaceuticals, Inc., a leading producer of high quality, all natural fiber supplements for improving digestive health, offers KonsylŪ Original as a powder-form, natural fiber supplement and bowel normalizer. Providing more fiber per dose than traditional bulk forming laxatives, Konsyl Orig ...

read more Konsyl Pharmaceuticals, Inc., a leading producer of high quality, all natural fiber supplements for improving digestive health, offers KonsylŪ Original as a powder-form, natural fiber supplement and bowel normalizer. Providing more fiber per dose than traditional bulk forming laxatives, Konsyl Orig read more Wed Dec 2006 Wed Dec 2006

AmitizaTM (lubiprostone) May Help Improve Symptoms Of Irritable Bowel Syndrome With Constipation

Categorie : Irritable-Bowel Syndrome
A new study found that AMITIZA? (lubiprostone) may help relieve the symptoms associated with constipation-predominant irritable bowel syndrome (IBS-C). IBS is a condition that affects nearly 30 million people in North America and accounts for 25-50 percent of referrals to gastroenterologists. The st ...

read more A new study found that AMITIZA? (lubiprostone) may help relieve the symptoms associated with constipation-predominant irritable bowel syndrome (IBS-C). IBS is a condition that affects nearly 30 million people in North America and accounts for 25-50 percent of referrals to gastroenterologists. The st read more Wed Dec 2006 Wed Dec 2006

Irritable-Bowel Syndrome News from Medical News Today

Categorie : Irritable-Bowel Syndrome
Latest Irritable-Bowel Syndrome news updated throughout the day, every day ...

read more Latest Irritable-Bowel Syndrome news updated throughout the day, every day read more Tue Aug 2006 Tue Aug 2006

Hypnotherapy Improves Quality Of Life For People With Irritable Bowel Syndrome

Categorie : Irritable-Bowel Syndrome
Patients with Irritable Bowel Syndrome (IBS) who took part in hypnotherapy sessions reported reduced symptoms and improved quality of life, according to research published in the June issue of Journal of Clinical Nursing. Dr Graeme D Smith from University of Edinburgh studied 75 patients with IBS - ...

read more Patients with Irritable Bowel Syndrome (IBS) who took part in hypnotherapy sessions reported reduced symptoms and improved quality of life, according to research published in the June issue of Journal of Clinical Nursing. Dr Graeme D Smith from University of Edinburgh studied 75 patients with IBS - read more Mon Aug 2006 Mon Aug 2006

1 | 2 | 3 next >>>



     


Custom Search